Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in surgical and medical patients and long-distance travelers in Latin America.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
    • Publication Information:
      Original Publication: Washington, DC : American Society of Hematology, [2016]-
    • Subject Terms:
      Hematology* ; Venous Thromboembolism*/drug therapy ; Venous Thromboembolism*/etiology ; Venous Thromboembolism*/prevention & control; Humans ; Latin America ; United States
    • Abstract:
      Background: Venous thromboembolism (VTE) is a common disease in Latin American settings. Implementation of international guidelines in Latin American settings requires additional considerations.
      Objective: To provide evidence-based guidelines about VTE prevention for Latin American patients, clinicians, and decision makers.
      Methods: We used the GRADE ADOLOPMENT method to adapt recommendations from 2 American Society of Hematology (ASH) VTE guidelines (Prevention of VTE in Surgical Patients and Prophylaxis for Medical Patients). ASH and 12 local hematology societies formed a guideline panel composed of medical professionals from 10 countries in Latin America. Panelists prioritized 20 questions relevant to the Latin American context. A knowledge synthesis team updated evidence reviews of health effects conducted for the original ASH guidelines and summarized information about factors specific to the Latin American context, that is, values and preferences, resources, accessibility, feasibility, and impact on health equity.
      Results: The panel agreed on 21 recommendations. In comparison with the original guideline, 6 recommendations changed direction and 4 recommendations changed strength.
      Conclusions: This guideline ADOLOPMENT project highlighted the importance of contextualization of recommendations in other settings, based on differences in values, resources, feasibility, and health equity impact.
      (© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
    • References:
      Blood Adv. 2018 Nov 27;2(22):3198-3225. (PMID: 30482763)
      J Clin Epidemiol. 2017 Jan;81:101-110. (PMID: 27713072)
      Blood Adv. 2019 Dec 10;3(23):3898-3944. (PMID: 31794602)
      Blood Adv. 2021 Aug 10;5(15):3047-3052. (PMID: 34374749)
      Semin Thromb Hemost. 1991;17 Suppl 3:304-12. (PMID: 1754886)
      Rev Panam Salud Publica. 2013 Feb;33(2):116-21, 3 p preceding 116. (PMID: 23525341)
      Ann Intern Med. 2015 Oct 6;163(7):548-53. (PMID: 26436619)
      Thromb Haemost. 2009 Nov;102(5):951-7. (PMID: 19888534)
      Rev Panam Salud Publica. 2013 Feb;33(2):90-7, 4 p preceding 90. (PMID: 23525338)
      Ann Intern Med. 2012 Apr 3;156(7):525-31. (PMID: 22473437)
      Medwave. 2017 Nov 27;17(9):e7083. (PMID: 29194433)
      Rev Panam Salud Publica. 2013 Feb;33(2):98-106, 2 p preceding 98. (PMID: 23525339)
      Gac Sanit. 2013 Jul-Aug;27(4):292-7. (PMID: 23433772)
      J Biosoc Sci. 2017 Sep;49(5):597-610. (PMID: 27825400)
      Rev Panam Salud Publica. 2002 May-Jun;11(5-6):335-55. (PMID: 12162831)
      J Clin Epidemiol. 2017 Jul;87:4-13. (PMID: 28529184)
      Rev Panam Salud Publica. 2013 Feb;33(2):131-6, 4 p preceding 131. (PMID: 23525343)
      BMJ. 2016 Jun 28;353:i2016. (PMID: 27353417)
      BMJ. 2008 Apr 26;336(7650):924-6. (PMID: 18436948)
      Rev Saude Publica. 2011 Oct;45(5):897-905. (PMID: 21829974)
      BMC Health Serv Res. 2010 Jul 23;10:217. (PMID: 20653970)
      Cien Saude Colet. 2017 Apr;22(4):1055-1064. (PMID: 28444033)
      Rev Panam Salud Publica. 2013 Feb;33(2):107-15, 6 p preceding 107. (PMID: 23525340)
      Int J Equity Health. 2017 Aug 22;16(1):149. (PMID: 28830521)
      J Thromb Haemost. 2006 Jun;4(6):1266-70. (PMID: 16706970)
      BMJ Open. 2014 Oct 03;4(10):e005502. (PMID: 25280806)
      Cien Saude Colet. 2017 Nov;22(11):3537-3546. (PMID: 29211159)
      Thromb J. 2011 Dec 15;9:18. (PMID: 22172213)
      Rev Panam Salud Publica. 2013 Feb;33(2):122-30, 9 p preceding 122. (PMID: 23525342)
      J Clin Epidemiol. 2011 Apr;64(4):383-94. (PMID: 21195583)
    • Publication Date:
      Date Created: 20220223 Date Completed: 20220623 Latest Revision: 20221105
    • Publication Date:
      20240104
    • Accession Number:
      PMC9631558
    • Accession Number:
      10.1182/bloodadvances.2021006482
    • Accession Number:
      35195676